Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.
Deutsch AJ, Rinner B, Wenzl K, Pichler M, Troppan K, Steinbauer E, Schwarzenbacher D, Reitter S, Feichtinger J, Tierling S, Prokesch A, Scheideler M, Krogsdam A, Thallinger GG, Schaider H, Beham-Schmid C, Neumeister P. Deutsch AJ, et al. Among authors: feichtinger j. Blood. 2014 Apr 10;123(15):2367-77. doi: 10.1182/blood-2013-08-518878. Epub 2014 Feb 19. Blood. 2014. PMID: 24553175 Free article.
NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Deutsch AJA, Rinner B, Pichler M, Prochazka K, Pansy K, Bischof M, Fechter K, Hatzl S, Feichtinger J, Wenzl K, Frisch MT, Stiegelbauer V, Prokesch A, Krogsdam A, Sill H, Thallinger GG, Greinix HT, Wang C, Beham-Schmid C, Neumeister P. Deutsch AJA, et al. Among authors: feichtinger j. Cancer Res. 2017 May 1;77(9):2375-2386. doi: 10.1158/0008-5472.CAN-16-2320. Epub 2017 Mar 1. Cancer Res. 2017. PMID: 28249906
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival.
Fechter K, Feichtinger J, Prochazka K, Unterluggauer JJ, Pansy K, Steinbauer E, Pichler M, Haybaeck J, Prokesch A, Greinix HT, Beham-Schmid C, Neumeister P, Thallinger GG, Deutsch AJA. Fechter K, et al. Among authors: feichtinger j. Sci Rep. 2018 Sep 28;8(1):14528. doi: 10.1038/s41598-018-32972-4. Sci Rep. 2018. PMID: 30266952 Free PMC article.
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
Uhl B, Prochazka KT, Pansy K, Wenzl K, Strobl J, Baumgartner C, Szmyra MM, Waha JE, Wolf A, Tomazic PV, Steinbauer E, Steinwender M, Friedl S, Weniger M, Küppers R, Pichler M, Greinix HT, Stary G, Ramsay AG, Apollonio B, Feichtinger J, Beham-Schmid C, Neumeister P, Deutsch AJ. Uhl B, et al. Among authors: feichtinger j. Int J Mol Sci. 2022 Jul 17;23(14):7874. doi: 10.3390/ijms23147874. Int J Mol Sci. 2022. PMID: 35887224 Free PMC article.
Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome.
Unterluggauer JJ, Prochazka K, Tomazic PV, Huber HJ, Seeboeck R, Fechter K, Steinbauer E, Gruber V, Feichtinger J, Pichler M, Weniger MA, Küppers R, Sill H, Schicho R, Neumeister P, Beham-Schmid C, Deutsch AJA, Haybaeck J. Unterluggauer JJ, et al. Among authors: feichtinger j. Blood Cancer J. 2018 Aug 22;8(9):79. doi: 10.1038/s41408-018-0112-5. Blood Cancer J. 2018. PMID: 30190479 Free PMC article. No abstract available.
The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.
Pansy K, Feichtinger J, Ehall B, Uhl B, Sedej M, Roula D, Pursche B, Wolf A, Zoidl M, Steinbauer E, Gruber V, Greinix HT, Prochazka KT, Thallinger GG, Heinemann A, Beham-Schmid C, Neumeister P, Wrodnigg TM, Fechter K, Deutsch AJ. Pansy K, et al. Among authors: feichtinger j. Int J Mol Sci. 2019 Sep 24;20(19):4740. doi: 10.3390/ijms20194740. Int J Mol Sci. 2019. PMID: 31554271 Free PMC article.
Resolving tumor heterogeneity: genes involved in chordoma cell development identified by low-template analysis of morphologically distinct cells.
El-Heliebi A, Kroneis T, Wagner K, Meditz K, Kolb D, Feichtinger J, Thallinger GG, Quehenberger F, Liegl-Atzwanger B, Rinner B. El-Heliebi A, et al. Among authors: feichtinger j. PLoS One. 2014 Feb 4;9(2):e87663. doi: 10.1371/journal.pone.0087663. eCollection 2014. PLoS One. 2014. PMID: 24503940 Free PMC article.
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions.
Pansy K, Uhl B, Krstic J, Szmyra M, Fechter K, Santiso A, Thüminger L, Greinix H, Kargl J, Prochazka K, Feichtinger J, Deutsch AJ. Pansy K, et al. Among authors: feichtinger j. Int J Mol Sci. 2021 Dec 10;22(24):13311. doi: 10.3390/ijms222413311. Int J Mol Sci. 2021. PMID: 34948104 Free PMC article. Review.
69 results